Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacitracin Patch Test Dose-Response Study
NCT00132600Phase 2Completed
- Sponsor
- SmartPractice Denmark
- Start
- Apr 2005
- Modality
- Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of bacitracin in allergic contact dermatitis (ACD), sponsored by SmartPractice Denmark. Primary endpoint: Skin reaction to the patch test at 7 days. Started Apr 2005; status: completed.
02
Drugs
bacitracin
03
Conditions
allergic contact dermatitis (ACD)
Beyond the preview
Go deeper on NCT00132600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132600.